Press Releases

Enovis Investor Relations: https://ir.enovis.com/

Wilmington, DE, Jan. 17, 2023 - Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced the launch of the DynaClip Delta™ and DynaClip Quattro™ bone staples, the latest additions to the Company’s growing foot and ankle portfolio and the DynaClip® family of bone fixation systems.

Designed to... Read more

WILMINGTON, Del., December 1, 2022 - Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the U.S. Food and Drug Administration (FDA) has approved the STAR Patient Specific Instrumentation (STAR PSI System) for use with the Company’s STAR® total ankle replacement system.

“Today is an exciting day for... Read more

WILMINGTON, Del., November 17, 2022 - Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announces the introduction of the DynaNail Helix™, the latest addition to the DynaNail® family and Enovis’ expansive suite of foot and ankle products. DynaNail Helix is designed to achieve sustained dynamic compression for subtalar fusion... Read more

WILMINGTON, Del., November 10, 2022 (BUSINESS WIRE) – Today, Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, announced that the company’s ARVIS® Augmented Reality Surgical Guidance System received the Industry Innovation Award at the this year’s American Academy of Hip and Knee Surgeons (AAHKS) Annual Meeting. This annual award... Read more

Wilmington, DE, Nov. 2, 2022 (GLOBE NEWSWIRE) - Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced its financial results for the third quarter of 2022. The Company will host an investor conference call and live webcast to discuss these results today at 8:00am ET. Read more

Pages